2seventy bio

2seventy bio is an American cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.
2seventy bio stock price chart
+5%
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

2seventy bio balance sheet

Report period2019 2020 2021
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

2seventy bio cash flows

Report period2019 2020 2021
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

2seventy bio multipliers

Report period2019 2020 2021
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

2seventy bio profitability

Report period2019 2020 2021
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
2seventy bio assets
2seventy bio cash flows

2seventy bio dividend policy

The company doesn't provide dividends

2seventy bio shares

TickerNameTypeNominal valueISINPrice
TSVT:US2seventy bioCommon share-US9013841070$14.55
TSVT-RM:RM2seventy bioCommon share$0.0001US9013841070RUB 481
2seventy bio news
13.05.2022
2seventy bio's GAAP loss for 3 months of 2022 was $85.711 million, down 1.7% from $87.196 million in the prior year. Revenue decreased 29.2% to $8.429 million from $11.901 million a year earlier.
22.03.2022
2seventy bio's GAAP loss for 2021 was $292.213 million, up 2.4 times from $120.114 million in the previous year. Revenue declined 4.6 times to $54.522 million from $248.122 million a year earlier.
01.12.2021
2seventy bio's GAAP loss for 9M 2021 was $231.237 mln, up 5.4 times from $43.313 mln in the previous year. 2021 was $231.237 million, up 5.4 times from $43.313 million in the previous year. Revenue declined 6.1 times to $38.488 million from $238.217 million a year earlier.
General information
Company name2seventy bio
Tags#biotechnology, #cancer treatment
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Biotechnology / Biotechnology
Business address60 Binney Street Cambridge, MA 02142 United States
Mailing address60 Binney Street Cambridge, MA 02142 United States
Websiteir.2seventybio.com